Kazia Therapeutics Secures $50M Private Placement to Strengthen Pipeline Funding
Sydney, Australia, December 3, 2025 — Kazia Therapeutics has announced the pricing of a US $50 million private placement...
Capital for New Therapy
BYT Launches NCIB Amid AGM Results to Strengthen Corporate Outlook
Vancouver, British Columbia — December 2, 2025 — BYT Holdings Ltd. announced its plan to initiate a Normal Course...
Tectonic Therapeutic Highlights GPCR Program at Investor Events
Watertown, Mass. — December 1, 2025 — Tectonic Therapeutic, Inc. announced that its executive leadership will participate in two...
Morphocell Secures $50M to Advance Stem-Cell Liver Therapy
Laval, Québec, December 1, 2025 — Morphocell Technologies has announced the successful completion of its US$50 million Series A...
Aspen Neuroscience Secures $115M to Advance Cell Therapy
SAN DIEGO, CA — November 20, 2025 — Aspen Neuroscience, a leading developer of personalized autologous cell therapies for...
Invivyd Secures $125M Financing to Accelerate Antiviral Pipeline
Dateline Introduction Waltham, Massachusetts — November 18, 2025 — Invivyd, a biotechnology company focused on developing innovative antiviral therapeutics,...
Gate Bioscience Raises $65M to Advance Molecular Gates
BRISBANE, CA – November 13, 2025 — Gate Bioscience announced the closing of an oversubscribed $65 million Series B...
Digitail Raises $23M Series B to Accelerate AI-Powered Vet Clinic Platform
Toronto, Canada – November 10, 2025 — Digitail, an AI-powered practice-management software platform for veterinary clinics, announced the completion...
Relmada Secures $100 Million to Accelerate CNS and Oncology Pipeline Expansion
CORAL GABLES, Fla., November 4, 2025 — Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage biopharmaceutical company focused on developing...
AAVantgarde Secures $141 Million Series B to Advance Gene Therapies for Retinal Diseases
LONDON/MILAN, Nov. 3, 2025 — AAVantgarde Bio has raised $141 million in a Series B financing round, co-led by...